Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?
, , et
28 mars 2022
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 28 mars 2022
Pages: 259 - 266
Reçu: 21 oct. 2021
Accepté: 31 janv. 2022
DOI: https://doi.org/10.2478/raon-2022-0010
Mots clés
© 2022 Dorota Maria Borowicz, Agnieszka Skrobała, Marta Kruszyna-Mochalska, Julian Malicki, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Borowicz, Dorota Maria
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Skrobała, Agnieszka
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Kruszyna-Mochalska, Marta
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland
Malicki, Julian
Department of Medical Physics, Greater Poland Cancer CentrePoznan, Poland
Electroradiology Department, University of Medical SciencesPoznan, Poland